UNI MEDICAL (02666) has announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd., intends to issue domestic medium-term notes to institutional investors in China.
The notes, designated as the second tranche of 2026 domestic medium-term notes, will have a principal amount of up to RMB 250 million, a two-year maturity, and a fixed interest rate to be determined through book-building upon the close of subscription applications.
The net proceeds from the note issuance will be used by the issuer to repay maturing debts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments